Reduced eGFR impairs toxin clearance and is linked to fatigue and cognitive decline.

Reduced kidney function, measured as a lower estimated glomerular filtration rate (eGFR), is scientifically established as a driver of systemic metabolic and neurological symptoms. This occurs through a direct failure of the renal filtration system and the subsequent accumulation of bioactive metabolites.

Clinical evidence of fatigue and cognitive decline

In older adults, declining eGFR is a robust predictor of both physical fatigue and cognitive deficits.

• Cognitive Impairment: Research indicates that the prevalence of cognitive impairment increases significantly as renal function drops. In individuals with an eGFR below 30 mL/min/1.73 m², the prevalence of cognitive impairment can exceed 60%, compared to approximately 10% in those with normal function. Clinical assessments like the MoCA show measurable declines in executive function and attention as eGFR falls below 60 mL/min/1.73 m².
• Systemic Fatigue: Fatigue affects between 50% and 70% of individuals with moderate to severe kidney disease (stages 3–5). The risk of hospitalization related to severe fatigue increases markedly once eGFR drops below 45 mL/min/1.73 m².

Mechanistic explanations for toxin accumulation

The kidney's primary role is the clearance of waste products, and a reduction in eGFR leads to the systemic accumulation of "uremic toxins" that are otherwise excreted.

• Failure of Clearance: As eGFR declines, the renal clearance of protein-bound toxins like indoxyl sulfate can drop from 26.7 mL/min in early disease stages to as low as 2.2 mL/min in advanced stages.
• Inflammatory Cascade: The retention of these toxins, specifically indoxyl sulfate and p-cresyl sulfate, triggers the production of reactive oxygen species (ROS). This leads to systemic inflammation, evidenced by elevated levels of C-reactive protein (CRP), Interleukin-6 (IL-6), and TNF-α. These inflammatory markers are known mediators of both central nervous system dysfunction and neuromuscular fatigue.

Bottom line

Declining eGFR directly impairs the clearance of uremic toxins and pro-inflammatory metabolites, creating a state of chronic systemic inflammation. For an older individual, this process is strongly associated with an increased risk of cognitive decline and persistent fatigue as kidney function diminishes.